These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6949537)

  • 1. Effects of high dose busulphan on leukaemic progenitor cells in chronic myeloid leukaemia.
    Morstyn G; Sullivan J; Fairhead S; Cowling D; Hurley T
    Aust N Z J Med; 1981 Dec; 11(6):609-14. PubMed ID: 6949537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collection and cryopreservation of peripheral blood progenitor cells in chronic granulocytic leukaemia--a comparison of treated and untreated patients.
    Norman JE; Shepherd KM; Dale BM; Sage RE
    Pathology; 1981 Jul; 13(3):609-14. PubMed ID: 6946388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of myleran on murine hemopoiesis. I. Granulocytic cell line specificity of action on progenitor cells.
    Delmonte L
    Cell Tissue Kinet; 1978 Jul; 11(4):347-58. PubMed ID: 308393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic granulocytic leukaemia with Ph 1 negative cells in bone marrow and a ten year remission after busulphan hypoplasia.
    Finney R; McDonald GA; Baikie AG; Douglas AS
    Br J Haematol; 1972 Sep; 23(3):283-8. PubMed ID: 4507535
    [No Abstract]   [Full Text] [Related]  

  • 5. Remission induction in chronic granulocytic leukaemia using intermittent high-dose busulphan.
    Douglas ID; Wiltshaw E
    Br J Haematol; 1978 Sep; 40(1):59-64. PubMed ID: 280361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different recovery patterns of mouse haemopoietic stem cells in response to cytotoxic agents.
    Blackett NM; Millard RE
    J Cell Physiol; 1976 Nov; 89(3):473-80. PubMed ID: 977663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal toxicity to myeloid progenitor cells of weekly 24-hr infusion of high-dose 5-fluorouracil: direct evidence from colony forming unit-granulocyte and monocyte (CFU-GM) clonogenic assay.
    Yeh KH; Yeh SH; Chang YS; Cheng AL
    Pharmacol Toxicol; 2000 Mar; 86(3):122-4. PubMed ID: 10752669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous busulphan for conditioning before autologous or allogeneic human blood stem cell transplantation.
    Schuler US; Renner UD; Kroschinsky F; Johne C; Jenke A; Naumann R; Bornhäuser M; Deeg HJ; Ehninger G
    Br J Haematol; 2001 Sep; 114(4):944-50. PubMed ID: 11564090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic granulocytic leukaemia with repeated single doses of busulphan.
    Vicariot M; Goldman JM; Catovsky D; Galton DA
    Eur J Cancer (1965); 1979 Apr; 15(4):559-63. PubMed ID: 285861
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of various cytotoxic agents on bone marrow progenitor cells as measured by diffusion chamber assays.
    Squires DJ; Lamerton LF
    Br J Haematol; 1975 Jan; 29(1):31-42. PubMed ID: 1201202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of modulation of glutathione cellular content on busulphan-induced cytotoxicity on hematopoietic cells in vitro and in vivo.
    Hassan Z; Hellström-Lindberg E; Alsadi S; Edgren M; Hägglund H; Hassan M
    Bone Marrow Transplant; 2002 Aug; 30(3):141-7. PubMed ID: 12189531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating granulocytic and erythroid progenitor cells in chronic granulocytic leukaemia.
    Goldman JM; Shiota F; Th'ng KH; Orchard KH
    Br J Haematol; 1980 Sep; 46(1):7-13. PubMed ID: 6932958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of differentiation of myeloid leukemic cells by busulphan: in vivo and in vitro observations.
    Michaeli J; Fibach E; Rachmilewitz EA
    Leuk Lymphoma; 1993 Oct; 11(3-4):287-91. PubMed ID: 8260900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro busulfan sensitivity of granulocyte-macrophage and erythroid progenitor cells in patients with chronic myelogenous leukemia.
    Kubota K; Preisler HD; Costanzo C; Miura Y
    Cancer Res; 1983 Dec; 43(12 Pt 1):6090-3. PubMed ID: 6580066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The maintenance of busulphan-induced remissions in chronic granulocytic leukaemia with recombinant interferon alpha-2b.
    Bergsagel DE; Messner H
    Br J Cancer; 1990 Jun; 61(6):895-8. PubMed ID: 2372493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-five year survival of chronic granulocytic leukaemia with spontaneous karyotype conversion.
    Singer CR; McDonald GA; Douglas AS
    Br J Haematol; 1984 Jun; 57(2):309-13. PubMed ID: 6587904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The myeloid progenitor cell: a parallel study of subpopulations in human marrow and peripheral blood.
    Verma DS; Spitzer G; Zander AR; Fisher R; McCredie KB; Dicke KA
    Exp Hematol; 1980 Jan; 8(1):32-43. PubMed ID: 6967823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between HLA-DR expression by normal myeloid progenitor cells and inhibition of colony growth by prostaglandin E. Implications for prostaglandin E resistance in chronic myeloid leukemia.
    Cannistra SA; Herrmann F; Davis R; Nichols K; Griffin JD
    J Clin Invest; 1986 Jan; 77(1):13-20. PubMed ID: 3455931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous transplantation with Philadelphia-negative progenitor cells for patients with chronic myeloid leukaemia (CML) failing to attain a cytogenetic response to alpha interferon.
    McBride NC; Cavenagh JD; Newland AC; Lillington DM; Murrell C; Kelsey SM
    Bone Marrow Transplant; 2000 Dec; 26(11):1165-72. PubMed ID: 11149726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myeloid leukaemia in Zambians.
    Lowenthal MN
    Trop Geogr Med; 1975 Jun; 27(2):132-6. PubMed ID: 1058559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.